Katharine Grimmer

774 citations
10 papers · 595 indexed · 3 hit papers · h-index 6
Topics
Liver Disease Diagnosis and Treatment (4 papers)Cancer, Lipids, and Metabolism (4 papers)Lung Cancer Treatments and Mutations (3 papers)

In The Last Decade

Katharine Grimmer

9 papers receiving 589 citations

Hit Papers

First-in-human study of the safety, pharmacokinetics, and...202120262022202420212021202450100150

Peers

Katharine Grimmer
Comparison fields: 5 of 64
  • Molecular Biology 339
  • Cancer Research 250
  • Epidemiology 192
  • Immunology 92
  • Oncology 83
Replace Zhe Yang with:
Zhe Yang China
Quentin Bayard France
Chen‐Hong Ding China
Xiju Wang China
Zhishi Yang China
Merima Herac Austria
Mitsuhiro Hishida Japan
Yifeng Tian China
Seo Hee Nam South Korea
Judit Peix Spain
Katharine Grimmer relative to Zhe Yang China Zhe Yang's profile →
Citations per field
00.5×
Zhe Yang · 1×
Citations per year

Countries citing papers authored by Katharine Grimmer

Since Specialization
Citations

This map shows the geographic impact of Katharine Grimmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharine Grimmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharine Grimmer more than expected).

Fields of papers citing papers by Katharine Grimmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharine Grimmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharine Grimmer. The network helps show where Katharine Grimmer may publish in the future.

Co-authorship network of co-authors of Katharine Grimmer

This figure shows the co-authorship network connecting the top 25 collaborators of Katharine Grimmer. A scholar is included among the top collaborators of Katharine Grimmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharine Grimmer. Katharine Grimmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 0
2
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trialbreakdown →
44
3 2
4 2
5
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumorsbreakdown →
192
6
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trialbreakdown →
163
7 3
8 8
9 167
10 14

About Katharine Grimmer

Katharine Grimmer is a scholar working on Hepatology, Cancer Research and Rehabilitation, having authored 10 papers that have together received 595 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Cancer Research (250 citations), Hepatology (51 citations) and Epidemiology (192 citations). Katharine Grimmer has collaborated with scholars based in United States, Hong Kong and France. Frequent co-authors include Marie O’Farrell, William McCulloch, Hartmut Koeppen, Scot A. Marsters, Avi Ashkenazi, Anan Chuntharapai, Kurt A. Schroeder, George Kemble, Rohit Loomba and Stephen A. Harrison. Their work appears in journals such as The Journal of Immunology, Gastroenterology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026